Department of Urology, University Hospital Heidelberg, Heidelberg, Germany; Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Urology, University Hospital Heidelberg, Heidelberg, Germany.
Eur Urol. 2016 Nov;70(5):846-853. doi: 10.1016/j.eururo.2015.12.052. Epub 2016 Jan 19.
Multiparametric magnetic resonance imaging (mpMRI) and MRI fusion targeted biopsy (FTB) detect significant prostate cancer (sPCa) more accurately than conventional biopsies alone.
To evaluate the detection accuracy of mpMRI and FTB on radical prostatectomy (RP) specimen.
DESIGN, SETTING AND PARTICIPANTS: From a cohort of 755 men who underwent transperineal MRI and transrectal ultrasound fusion biopsy under general anesthesia between 2012 and 2014, we retrospectively analyzed 120 consecutive patients who had subsequent RP. All received saturation biopsy (SB) in addition to FTB of lesions with Prostate Imaging Reporting and Data System (PI-RADS) score ≥2.
The index lesion was defined as the lesion with extraprostatic extension, the highest Gleason score (GS), or the largest tumor volume (TV) if GS were the same, in order of priority. GS 3+3 and TV ≥1.3ml or GS ≥3+4 and TV ≥0.55ml were considered sPCa. We assessed the detection accuracy by mpMRI and different biopsy approaches and analyzed lesion agreement between mpMRI and RP specimen.
Overall, 120 index and 71 nonindex lesions were detected. Overall, 107 (89%) index and 51 (72%) nonindex lesions harbored sPCa. MpMRI detected 110 of 120 (92%) index lesions, FTB (two cores per lesion) alone diagnosed 96 of 120 (80%) index lesions, and SB alone diagnosed 110 of 120 (92%) index lesions. Combined SB and FTB detected 115 of 120 (96%) index foci. FTB performed significantly less accurately compared with mpMRI (p=0.02) and the combination for index lesion detection (p=0.002). Combined FTB and SB detected 97% of all sPCa lesions and was superior to mpMRI (85%), FTB (79%), and SB (88%) alone (p<0.001 each). Spearman's rank correlation coefficient for index lesion agreement between mpMRI and RP was 0.87 (p<0.001). Limitations included the retrospective design, multiple operators, and nonblinding of radiologists.
MpMRI identified 92% of index lesions compared with RP histopathology. The combination of FTB and SB was superior to both approaches alone, reliably detecting 97% of sPCa lesions.
Multiparametric magnetic resonance imaging detects the index lesion accurately in 9 of 10 patients; however, the combined biopsy approach, while missing less significant cancer, comes at the cost of detecting more insignificant cancer.
多参数磁共振成像(mpMRI)和 MRI 融合靶向活检(FTB)比传统活检更能准确检测出显著前列腺癌(sPCa)。
评估 mpMRI 和 FTB 在根治性前列腺切除术(RP)标本中的检测准确性。
设计、地点和参与者:从 2012 年至 2014 年间接受经会阴 MRI 和经直肠超声融合活检的 755 名男性队列中,我们回顾性分析了随后接受 RP 的 120 名连续患者。所有患者均接受了饱和活检(SB),并对前列腺成像报告和数据系统(PI-RADS)评分≥2 的病变进行了 FTB。
总体而言,共检测到 120 个指数病变和 71 个非指数病变。总体而言,107 个(89%)指数病变和 51 个(72%)非指数病变存在 sPCa。mpMRI 检测到 120 个指数病变中的 110 个,FTB(每病变两个核心)单独诊断出 120 个指数病变中的 96 个,SB 单独诊断出 120 个指数病变中的 110 个。联合 SB 和 FTB 检测到 120 个指数病灶中的 115 个。FTB 的准确性明显低于 mpMRI(p=0.02)和联合检测指数病变(p=0.002)。联合 FTB 和 SB 检测到所有 sPCa 病变的 97%,优于 mpMRI(85%)、FTB(79%)和 SB(88%)单独检测(p<0.001 各)。mpMRI 和 RP 之间指数病变的 Spearman 秩相关系数为 0.87(p<0.001)。局限性包括回顾性设计、多个操作者和放射科医生的非盲法。
mpMRI 与 RP 组织病理学相比,可准确识别 92%的指数病变。FTB 和 SB 的联合应用优于单独应用,可可靠地检测到 97%的 sPCa 病变。
多参数磁共振成像在 9 例患者中的 10 例中准确检测到了指数病变;然而,联合活检方法虽然漏诊了一些不那么显著的癌症,但却以检测到更多不显著的癌症为代价。